Legal MilestoneFavorable Court Ruling for Dexcom with a U.S. District Court of Delaware patent jury decision indicating no infringement, which supports a positive outlook for the company's intellectual property and market position.
Market Expansion StrategyWith Stelo's over-the-counter availability, Dexcom is poised to tap into a significant patient pool, bolstered by competitive pricing, direct-to-consumer marketing, and efforts to build payer coverage.
Product Approval And Market PotentialFDA approval of Stelo, Dexcom's 15-day sensor for type 2 non-insulin users, now cleared for over-the-counter sales, potentially opening up a new total addressable market that's not yet reflected in the current stock price.